[
  {
    "ts": null,
    "headline": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
    "summary": "Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO stock a buy.",
    "url": "https://finnhub.io/api/news?id=3122007dae2978956606ea7a5228db0ac0ef5a4180bc8ae0df8c2091a0d4e554",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740009540,
      "headline": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
      "id": 132792928,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1156718067/image_1156718067.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO stock a buy.",
      "url": "https://finnhub.io/api/news?id=3122007dae2978956606ea7a5228db0ac0ef5a4180bc8ae0df8c2091a0d4e554"
    }
  },
  {
    "ts": null,
    "headline": "Securities Fraud Investigation Into Merck & Co (MRK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz",
    "summary": "The Law Offices of Frank R. Cruz announces an investigation of Merck & Co on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR...",
    "url": "https://finnhub.io/api/news?id=1b8b3a7f9afe7db941a6c1644a409ccf70f635c84b6a9631c3993ed26b80f34b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739998863,
      "headline": "Securities Fraud Investigation Into Merck & Co (MRK) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz",
      "id": 132792273,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "The Law Offices of Frank R. Cruz announces an investigation of Merck & Co on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR...",
      "url": "https://finnhub.io/api/news?id=1b8b3a7f9afe7db941a6c1644a409ccf70f635c84b6a9631c3993ed26b80f34b"
    }
  },
  {
    "ts": null,
    "headline": "10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers",
    "summary": "Discover our top dividend-yield stocks & reader favorites for 2025! See the best performers by net gains, price upside, and yield. Click for the exclusive picks.",
    "url": "https://finnhub.io/api/news?id=28ffebdbb9b2491e4260010eacb12301c74fc6c7b69600ea32233974bfa8f519",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739988476,
      "headline": "10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers",
      "id": 132791627,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291579521/image_1291579521.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Discover our top dividend-yield stocks & reader favorites for 2025! See the best performers by net gains, price upside, and yield. Click for the exclusive picks.",
      "url": "https://finnhub.io/api/news?id=28ffebdbb9b2491e4260010eacb12301c74fc6c7b69600ea32233974bfa8f519"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=f3f95e4e0531b0152994086104a9c4d19b2305d9d9794ad6c4fc5a94d5beeaaf",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739982840,
      "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "id": 132796833,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f3f95e4e0531b0152994086104a9c4d19b2305d9d9794ad6c4fc5a94d5beeaaf"
    }
  },
  {
    "ts": null,
    "headline": "Merck - WELIREG Receives First European Commission Approval for Two Indications",
    "summary": "RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the European Commission has conditionally approved WELIREG , Merck's oral hypoxia-inducible factor-2 alpha ...",
    "url": "https://finnhub.io/api/news?id=bf2f0938d07d72099f88cab8fa692d446d4a0023b72c373f77b27d1944809d24",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739965544,
      "headline": "Merck - WELIREG Receives First European Commission Approval for Two Indications",
      "id": 132787520,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced that the European Commission has conditionally approved WELIREG , Merck's oral hypoxia-inducible factor-2 alpha ...",
      "url": "https://finnhub.io/api/news?id=bf2f0938d07d72099f88cab8fa692d446d4a0023b72c373f77b27d1944809d24"
    }
  },
  {
    "ts": null,
    "headline": "Deutsche Bank Downgrades Merck (MRK)",
    "summary": "Deutsche Bank Downgrades Merck (MRK)",
    "url": "https://finnhub.io/api/news?id=c823d883a41747e06403c7c4c8a380f9d5044da935d75c037171131ea3c4035a",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739923446,
      "headline": "Deutsche Bank Downgrades Merck (MRK)",
      "id": 132780782,
      "image": "",
      "related": "MRK",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=c823d883a41747e06403c7c4c8a380f9d5044da935d75c037171131ea3c4035a"
    }
  }
]